Cogent Biosciences Inc (COGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 0 | 0 | 0 | 0 | 7,871 |
| Gross Profit | N/A | N/A | N/A | N/A | 7,871 |
| Operating Expenses | 275,939 | 208,130 | 147,839 | 75,551 | 90,070 |
| Operating Income | -275,939 | -208,130 | -147,839 | -75,551 | -82,199 |
| Other Income | 20,080 | 15,720 | 7,598 | 3,278 | 7,391 |
| Pre-tax Income | -255,859 | -192,410 | -140,241 | -72,273 | -74,808 |
| Net Income Continuous | -255,859 | -192,410 | -140,241 | -72,273 | -74,808 |
| Net Income | $-255,859 | $-192,410 | $-140,241 | $-72,273 | $-74,808 |
| EPS Basic Total Ops | -1.94 | -1.94 | -1.73 | -1.87 | -16.17 |
| EPS Basic Continuous Ops | -2.46 | -2.42 | -2.39 | -1.87 | -6.75 |
| EPS Diluted Total Ops | -1.94 | -1.94 | -1.73 | -1.87 | -16.17 |
| EPS Diluted Continuous Ops | -2.46 | -2.42 | -2.39 | -1.87 | -6.75 |
| EPS Diluted Before Non-Recurring Items | -1.94 | -2.42 | -2.39 | -1.87 | -16.08 |
| EBITDA(a) | $-281,108 | $-211,033 | $-148,635 | $-75,404 | $-81,479 |